EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Oral peptide therapeutics for diabetes treatment: State-of-the-art and future perspectives

Bingwen Ding, Zhu Zhu, Cong Guo, Jiaxin Li, Yong Gan, Miaorong Yu

Acta Pharmaceutica Sinica B · 2024-05 · 14 (5) · 2006-2025

DOI: 10.1016/j.apsb.2024.02.019 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Acta Pharmaceutica Sinica B, 2024-05. Verfasst von Bingwen Ding und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Drug Research and Center of Pharmaceutics, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203…. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 193 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Chinese Academy of Sciences, China Academy of Space Technology, National Science Fund for Distinguished Young Scholars.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

BiodistributionBiological barriersDelivery platformsDiabetesGlucagon-like peptide-1InsulinOral peptidesTargeted delivery

Autor:innen und Institutionen

  • State Key Laboratory of Drug Research and Center of Pharmaceutics, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
  • University of Chinese Academy of Sciences, Beijing 100049, China.
  • School of Pharmacy, Henan University, Kaifeng 475004, China.
  • NMPA Key Laboratory for Quality Research and Evaluation of Pharmaceutical Excipients, National Institutes for Food and Drug Control, Beijing 100050, China.

Förderung

  • Chinese Academy of Sciences
  • China Academy of Space Technology
  • National Science Fund for Distinguished Young Scholars
  • National Natural Science Foundation of China

Zitieren

APA

Ding, B., Zhu, Z., Guo, C., Li, J., Gan, Y., & Yu, M. (2024). Oral peptide therapeutics for diabetes treatment: State-of-the-art and future perspectives. Acta Pharmaceutica Sinica B, 14(5), 2006-2025. https://doi.org/10.1016/j.apsb.2024.02.019

Vancouver

Ding B, Zhu Z, Guo C, Li J, Gan Y, Yu M. Oral peptide therapeutics for diabetes treatment: State-of-the-art and future perspectives. Acta Pharmaceutica Sinica B. 2024;14(5):2006-2025. doi:10.1016/j.apsb.2024.02.019

BibTeX
@article{Ding2024,
  author = {Ding, Bingwen and Zhu, Zhu and Guo, Cong and Li, Jiaxin and Gan, Yong and Yu, Miaorong},
  title = {Oral peptide therapeutics for diabetes treatment: State-of-the-art and future perspectives},
  journal = {Acta Pharmaceutica Sinica B},
  year = {2024},
  volume = {14},
  number = {5},
  pages = {2006--2025},
  doi = {10.1016/j.apsb.2024.02.019}
}
Kostenlos starten →